Visicell’s VMI-Trac, “GPS for Cell Therapy”, is a non-invasive, rapid, imaging system which allows real time, quantitative tracking of cellular therapies in patients and animals using common MRI machines to understand cellular therapy biodistribution, efficacy, dose and safety. VMI-Trac allows for repeated monitoring of the cell therapies for up to several months post dosing and is designed to fit into the typical imaging workflows used for disease monitoring. The customer-validated benefits help address major challenges in the development and commercialization of cellular therapies, including early detection of efficacy, patient selection, dose selection, safety, faster clinical development, and clinical decision making.